Micronoma News and Resources

News

Micronoma Teams Up with NYU Grossman School of Medicine on Lung Cancer Research Grant Utilizing Microbial Biomarkers

<img decoding="async" fetchpriority="high" src="https://micronoma.com/wp-content/uploads/2023/03/Untitled-design-25-1080x272.png" alt="Micronoma Teams Up with NYU Grossman School of Medicine on Lung Cancer Research Grant Utilizing Microbial Biomarkers" class="" width="1080" height="675" srcset="https://micronoma.com/wp-content/uploads/2023/03/Untitled-design-25-980x133.png 980w, https://micronoma.com/wp-content/uploads/2023/03/Untitled-design-25-480x65.png 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" />

Micronoma Teams Up with NYU Grossman School of Medicine on Lung Cancer Research Grant Utilizing Microbial Biomarkers

May 18, 2023

This latest collaboration seeks synergistic methodologies that will enable the earliest, best...

Micronoma Breaks Through With Microbiome-BIOTECH: FDA Designation a ‘Milestone’

Micronoma Breaks Through With Microbiome-BIOTECH: FDA Designation a ‘Milestone’

Feb 8, 2023

Micronoma’s microbiome platform is breaking into its next phase with validation from the U.S. Food...

FDA Grants Novel Liquid Biopsy Assay Breakthrough Device Designation to Detect Lung Cancer

FDA Grants Novel Liquid Biopsy Assay Breakthrough Device Designation to Detect Lung Cancer

Jan 30, 2023

The FDA has granted breakthrough device designation to the novel, microbiome-driven, liquid biopsy...

In Brief This Week: Micronoma, Legend Biotech, Point Biopharma, AstraZeneca, Daiichi Sankyo, Takeda,

In Brief This Week: Micronoma, Legend Biotech, Point Biopharma, AstraZeneca, Daiichi Sankyo, Takeda,

Jan 30, 2023

Read more at Precision Oncology News

More News

Announcements

Micronoma Teams Up with NYU Grossman School of Medicine on Lung Cancer Research Grant Utilizing Microbial Biomarkers

<img decoding="async" fetchpriority="high" src="https://micronoma.com/wp-content/uploads/2023/03/Untitled-design-25-1080x272.png" alt="Micronoma Teams Up with NYU Grossman School of Medicine on Lung Cancer Research Grant Utilizing Microbial Biomarkers" class="" width="1080" height="675" srcset="https://micronoma.com/wp-content/uploads/2023/03/Untitled-design-25-980x133.png 980w, https://micronoma.com/wp-content/uploads/2023/03/Untitled-design-25-480x65.png 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1080px, 100vw" />

Micronoma Teams Up with NYU Grossman School of Medicine on Lung Cancer Research Grant Utilizing Microbial Biomarkers

May 18, 2023

This latest collaboration seeks synergistic methodologies that will enable the earliest, best...

Micronoma Presents State-of-the-Art Metagenomic Liquid Biopsy

Apr 27, 2023

AACR 2023 presentation highlights noteworthy diagnostic performance potential using cell-free...

Frost & Sullivan Lauds Micronoma with Award for Technology Innovation Leadership

Mar 30, 2023

Analysts credit the Oncobiota microbiome-driven liquid biopsy platform for identifyingthe...

Micronoma Receives FDA Breakthrough Device Designation for OncobiotaLUNG, A Novel Liquid Biopsy Assay for Lung Carcinoma Detection

Jan 10, 2023

The OncobiotaLUNG assay is the first blood microbiome-driven liquid biopsy created to detect lung...

More Announcements

Meet us at these

upcoming conferences

Untitled design (15)

Website Terms of Use, Privacy Policy, and Licenses and Accreditations

Micronoma, INC., CLIA #05D2253538

Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.

HIPAA Statement | GDPR Notice

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.

Micronoma
6342 Ferris Square
San Diego, CA 92121